ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 59 filers reported holding ADMA BIOLOGICS INC in Q1 2019. The put-call ratio across all filers is 7.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,400,000 | -2.0% | 600,000 | +9.1% | 1.63% | -13.3% |
| Q3 2019 | $2,448,000 | +15.0% | 550,000 | 0.0% | 1.88% | +28.2% |
| Q2 2019 | $2,129,000 | -2.3% | 550,000 | -4.3% | 1.47% | -6.0% |
| Q1 2019 | $2,179,000 | +127.9% | 575,000 | +43.8% | 1.56% | +83.4% |
| Q4 2018 | $956,000 | -59.0% | 400,000 | +6.7% | 0.85% | -44.2% |
| Q3 2018 | $2,329,000 | +37.7% | 375,000 | 0.0% | 1.52% | +27.1% |
| Q2 2018 | $1,691,000 | +22.5% | 375,000 | +25.0% | 1.20% | +14.2% |
| Q1 2018 | $1,380,000 | -14.0% | 300,000 | -40.0% | 1.05% | -16.9% |
| Q4 2017 | $1,605,000 | – | 500,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |